Neoadjuvant therapy for advanced head and neck cancer with allopurinol-modulated high dose 5-fluorouracil and cisplatin a phase I-II study (original) (raw)

Intensive chemotherapy using cisplatin and fluorouracil followed by radiotherapy in advanced head and neck cancer

Eduardo Rosenblatt

Oral Oncology, 1997

View PDFchevron_right

Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancer

John Jacobs

American Journal of Surgery, 1984

View PDFchevron_right

Induction Chemotherapy (Cisplatin + 5-Fluorouracil) and Radiotherapy in Advanced Squamous Cell Carcinoma of the Head and Neck

Anders Biörklund

Acta Oncologica, 1991

View PDFchevron_right

A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5‐fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck

M. Biglietto, Giacomo Carteni

Cancer, 1999

View PDFchevron_right

Pilot study of intraoperative chemotherapy with cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the head and neck

Lance Heilbrun

Head & Neck, 2007

View PDFchevron_right

Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5FU infusion and cisplatin

John Jacobs

Cancer, 1985

View PDFchevron_right

Docetaxel, Cisplatin, Leucovorin and 5- Fluorouracil versus Leucovorin, 5-Fluorouracil, and Cisplatin as Neoadjuvant Chemotherapy Followed by Chemoradiation in Head and Neck Cancer

Akramul Islam

SAS journal of medicine, 2023

View PDFchevron_right

Systemic Chemotherapy with Cisplatin Plus 5-FU (PF) for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN): Efficacy and Safety of a Lower Dose of PF (80/800) at a Single Institution in Japan

Naomi Kiyota

Japanese Journal of Clinical Oncology, 2009

View PDFchevron_right

Cis-platinum and 5-fluorouracil as induction therapy for advanced head and neck cancer

Muhyi Al-Sarraf

The American Journal of Surgery, 1982

View PDFchevron_right

Induction chemotherapy with docetaxel, cisplatin, fluorouracil and l-leucovorin for locally advanced head and neck cancers: a modified regimen for Japanese patients

Andrea Berghold

Anti-Cancer Drugs, 2003

View PDFchevron_right

Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck

Maurice Schneider

British Journal of Cancer, 1986

View PDFchevron_right

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

Ricard Mesía

New England Journal of Medicine, 2007

View PDFchevron_right

Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: A randomised phase II study

Antonio Rueda Lara

European Journal of Cancer, 2005

View PDFchevron_right

Radiochemotherapy Including Cisplatin Alone versus Cisplatin + 5Fluorouracil for Locally Advanced Unresectable Stage IV Squamous Cell Carcinoma of the Head and Neck

George Hakim

Strahlentherapie Und Onkologie, 2009

View PDFchevron_right

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer

Roy Vera

New England Journal of Medicine, 2007

View PDFchevron_right

Concomitant chemo/radiotherapy for advanced carcinoma of the head and neck

Patrick Bradley

British Journal of Radiology, 1991

View PDFchevron_right

Concurrent radiotherapy and continuous ambulatory infusion 5-fluorouracil in advanced head and neck cancer

Kailash Narayan

European Journal of Cancer, 1996

View PDFchevron_right

Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (MO) disease

Esteban Cvitkovic

Cancer, 1991

View PDFchevron_right

Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study

Joseph Kerger, Carl Van Laer

Annals of Oncology, 2004

View PDFchevron_right

Cisplatin, Fluorouracil, and Leucovorin Induction Chemotherapy Followed by Concurrent Cisplatin Chemoradiotherapy for Organ Preservation and Cure in Patients With Advanced Head and Neck Cancer: Long-Term Follow-Up

Barbara Burtness

Journal of Clinical Oncology, 2004

View PDFchevron_right

A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas

M. Amin Mosleh-Shirazi

Iranian Red Crescent Medical Journal, 2011

View PDFchevron_right

Enhanced acute toxicity in oropharynx carcinoma treated with radiotherapy and concomitant cisplatin, 5-fluorouracil and mitomycin C

S. Chapet

European Journal of Cancer, 1996

View PDFchevron_right

Response Rate and Toxicity of Docetaxel / Cisplatin /5FU in Comparison with Cisplatin / 5FU Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

ahmad ameri

2013

View PDFchevron_right

Induction chemotherapy in head and neck cancer

Laval Grimard

Annals of Oncology, 2006

View PDFchevron_right